DE68903059D1 - Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten. - Google Patents
Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.Info
- Publication number
- DE68903059D1 DE68903059D1 DE8989401861T DE68903059T DE68903059D1 DE 68903059 D1 DE68903059 D1 DE 68903059D1 DE 8989401861 T DE8989401861 T DE 8989401861T DE 68903059 T DE68903059 T DE 68903059T DE 68903059 D1 DE68903059 D1 DE 68903059D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- products containing
- medicinal products
- strontium salt
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrrole Compounds (AREA)
- Light Receiving Elements (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8808729A FR2633619B1 (fr) | 1988-06-29 | 1988-06-29 | Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68903059D1 true DE68903059D1 (de) | 1992-11-05 |
DE68903059T2 DE68903059T2 (de) | 1993-04-29 |
Family
ID=9367847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8989401861T Expired - Fee Related DE68903059T2 (de) | 1988-06-29 | 1989-06-29 | Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten. |
Country Status (16)
Country | Link |
---|---|
US (1) | US4939164A (de) |
EP (1) | EP0349432B1 (de) |
JP (1) | JPH0248567A (de) |
AT (1) | ATE81118T1 (de) |
AU (1) | AU613297B2 (de) |
CA (1) | CA1312333C (de) |
DE (1) | DE68903059T2 (de) |
DK (1) | DK325289A (de) |
ES (1) | ES2044170T3 (de) |
FR (1) | FR2633619B1 (de) |
GR (1) | GR3006674T3 (de) |
IE (1) | IE64112B1 (de) |
NZ (1) | NZ229760A (de) |
OA (1) | OA09121A (de) |
PT (1) | PT91006B (de) |
ZA (1) | ZA894945B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7404967B2 (en) * | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
FR2749759B1 (fr) * | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
AU2004237438B2 (en) * | 2003-05-07 | 2011-01-20 | Osteologix A/S | Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
CA2519189C (en) * | 2003-05-07 | 2012-07-17 | Osteologix A/S | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
EP1732575B1 (de) * | 2004-02-26 | 2010-12-29 | Osteologix A/S | Strontiumhaltige verbindungen zur verwendung bei prävention oder behandlung nekrotisierender knochenkrankheiten |
DK1768748T4 (da) | 2004-06-25 | 2019-06-11 | Mokwalo Spf S A | Sammensætninger omfattende strontium og vitamin D og anvendelser deraf |
US7875627B2 (en) * | 2004-12-07 | 2011-01-25 | Abbott Laboratories | Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof |
EP2530068A1 (de) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | Neue Strontiumsalze, deren Synthese und Verwendung bei der Behandlung von Osteoporose |
EP3206803A1 (de) | 2014-10-14 | 2017-08-23 | Unilever NV | Sprühvorrichtung |
US10385560B2 (en) | 2014-10-14 | 2019-08-20 | Conopco, Inc. | Device for spraying an enclosure triggered by inclination of a rotatable lid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2954384A (en) * | 1960-09-27 | Method for preparing kainic acid and its | ||
DE3127275A1 (de) * | 1980-12-11 | 1983-01-27 | Leskovar, Peter, Dr.-Ing., 8000 München | "harnsteinaufloesende mittel" |
-
1988
- 1988-06-29 FR FR8808729A patent/FR2633619B1/fr not_active Expired - Lifetime
-
1989
- 1989-06-20 US US07/368,593 patent/US4939164A/en not_active Expired - Fee Related
- 1989-06-26 ZA ZA894945A patent/ZA894945B/xx unknown
- 1989-06-27 CA CA000604039A patent/CA1312333C/fr not_active Expired - Fee Related
- 1989-06-28 PT PT91006A patent/PT91006B/pt not_active IP Right Cessation
- 1989-06-28 IE IE209489A patent/IE64112B1/en not_active IP Right Cessation
- 1989-06-28 NZ NZ229760A patent/NZ229760A/en unknown
- 1989-06-28 OA OA59600A patent/OA09121A/xx unknown
- 1989-06-28 AU AU37092/89A patent/AU613297B2/en not_active Ceased
- 1989-06-29 AT AT89401861T patent/ATE81118T1/de not_active IP Right Cessation
- 1989-06-29 ES ES89401861T patent/ES2044170T3/es not_active Expired - Lifetime
- 1989-06-29 DE DE8989401861T patent/DE68903059T2/de not_active Expired - Fee Related
- 1989-06-29 DK DK325289A patent/DK325289A/da not_active Application Discontinuation
- 1989-06-29 JP JP1168247A patent/JPH0248567A/ja active Granted
- 1989-06-29 EP EP89401861A patent/EP0349432B1/de not_active Expired - Lifetime
-
1992
- 1992-12-24 GR GR920403112T patent/GR3006674T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE64112B1 (en) | 1995-07-12 |
CA1312333C (fr) | 1993-01-05 |
AU613297B2 (en) | 1991-07-25 |
DK325289D0 (da) | 1989-06-29 |
JPH0248567A (ja) | 1990-02-19 |
JPH0587064B2 (de) | 1993-12-15 |
FR2633619A1 (fr) | 1990-01-05 |
FR2633619B1 (fr) | 1991-02-08 |
OA09121A (fr) | 1991-10-31 |
PT91006B (pt) | 1994-11-30 |
NZ229760A (en) | 1991-06-25 |
DK325289A (da) | 1989-12-30 |
ATE81118T1 (de) | 1992-10-15 |
DE68903059T2 (de) | 1993-04-29 |
EP0349432B1 (de) | 1992-09-30 |
EP0349432A1 (de) | 1990-01-03 |
IE892094L (en) | 1989-12-29 |
US4939164A (en) | 1990-07-03 |
ES2044170T3 (es) | 1994-01-01 |
AU3709289A (en) | 1990-01-04 |
PT91006A (pt) | 1989-12-29 |
ZA894945B (en) | 1990-03-28 |
GR3006674T3 (de) | 1993-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE232543T1 (de) | 11beta-halogen-7alpha-substituierte-estratriene verfahren zur herstellung pharmazeutischer präparate, die diese 11beta-halogen-7alpha- substituierte-estratriene enthalten, sowie deren verwendung zur herstellung von arzneimitteln | |
DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
ATE30575T1 (de) | Stabilisierter aktivierter sauerstoff und arzneimittel, die diesen stabilisierten aktivierten sauerstoff enthalten. | |
DE3485075D1 (de) | Pharmazeutische zubereitung zur heilung der erkrankungen der zahnwurzelhaut und verfahren zu deren herstellung. | |
ATE231882T1 (de) | 7alpha-(epsilon-aminoalkyl)-estratriene, verfahren zu deren herstellung, pharmazeutische präparate, die diese 7alpha-(epsilon-aminoalkyl)- estratriene enthalten sowie deren verwendung zur herstellung von arzneimitteln | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
EP0793660A4 (de) | 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung | |
DE68903059D1 (de) | Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten. | |
DE3782621D1 (de) | Imidazol-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, welche diese enthalten, verwendung dieser zur herstellung therapeutisch wirksamer arzneimittel und zwischenprodukte, welche beim herstellungsverfahren entstehen. | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
ATE137237T1 (de) | R-(-)-1-(5-hydroxyhexyl)-3-methyl-7- propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel | |
ATE152350T1 (de) | Pharmazeutische zusammensetzungen die 5- difluormethoxy-2-(3,4-dimethoxy-2- pyridyl)methylsulfinyl>-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten | |
DE3787437D1 (de) | Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems. | |
ATA67488A (de) | Immunglobulinkonjugate, verfahren zu deren herstellung und anwendung sowie pharmazeutische mittel, die diese enthalten | |
AT399504B (de) | Neue aminopropoxyimino-cycloalkanderivate, deren herstellung, arzneimittel, die diese verbindungen als wirkstoff enthalten sowie verfahren zur herstellung derselben | |
ATE109144T1 (de) | Furylthiazol-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
PT70560A (de) | 1,3,4-thiadiazol-2-carbonsaure-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende fungizide und nematizide mittel | |
HUT50633A (en) | Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives | |
ATE112276T1 (de) | Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
JPS5753475A (en) | Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same | |
DE68925387D1 (de) | Verfahren zur Behandlung von Immunotest-Proben, die Schleim enthalten | |
DE68915750D1 (de) | Kathecholverbindungen, verfahren zur herstellung und arzneimittelzubereitung, die diese enthält. | |
SE8105500L (sv) | Psykotropa lekemedel | |
MX9704036A (es) | 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso. | |
ATE66468T1 (de) | Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |